Regulation, role and future of named patient products in Germany

Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009:96:193-7; discussion 197-9.
No abstract available

MeSH terms

  • Allergens* / isolation & purification
  • Allergens* / therapeutic use
  • Desensitization, Immunologic
  • Germany
  • Government Regulation
  • Humans
  • Reference Standards

Substances

  • Allergens